Basosquamous Carcinoma: A Skin Cancer That Refuses to Sit in One Box
Basosquamous carcinoma blends basal cell and squamous cell features, and its disputed classification continues to shape how dermatologists diagnose, stage and manage it.
Topic
Topic
Basosquamous carcinoma blends basal cell and squamous cell features, and its disputed classification continues to shape how dermatologists diagnose, stage and manage it.
UC San Diego Health is offering a band-aid-style adhesive patch to treat skin cancer, moving topical tumor therapy into a wearabl…
Krystal Biotech reports KB113, a topical gene therapy candidate, drove lesion regression in Gorlin syndrome patients — an early s…
Photodynamic therapy won regulatory approval for basal cell carcinoma, the most common skin cancer in the United States, MedPage…
Yale Medicine's new patient guide spans the skin cancer spectrum, from basal cell carcinoma to melanoma. Here's what practitioner…
Dermatology Times opens a case series on surgery-refractory BCC, starting with a recurrent temple tumor in one of the face's high…
A Dermatology Times feature reframes hedgehog pathway inhibitor care for advanced BCC around the monitoring workflow — the labs,…
Medscape reports AI-assisted tomography now detects subclinical basal cell carcinomas, a finding that could reshape Mohs margin p…
A Journal of Investigative Dermatology study published October 9, 2026 maps how Wnt/β-catenin pathway components sustain pre–basa…
JAAD published an expert opinion on October 8, 2026 comparing efficacy and tolerability of hedgehog pathway inhibitors for locall…